Venous Thromboembolism Clinical Trials

58 recruiting

Venous Thromboembolism Trials at a Glance

76 actively recruiting trials for venous thromboembolism are listed on ClinicalTrialsFinder across 6 cities in 43 countries. The largest study group is Not Applicable with 16 trials, with the heaviest enrollment activity in Ottawa, Boston, and Clermont-Ferrand. Lead sponsors running venous thromboembolism studies include Ottawa Hospital Research Institute, University Hospital, Brest, and Imperial College London.

Browse venous thromboembolism trials by phase

Treatments under study

About Venous Thromboembolism Clinical Trials

Looking for clinical trials for Venous Thromboembolism? There are currently 58 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Venous Thromboembolism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Venous Thromboembolism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 76 trials

Recruiting
Not Applicable

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Deep Venous ThrombosisVenous Thromboembolism
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital2,400 enrolled5 locationsNCT06950697
Recruiting

Evaluation of the SCALED (SCaling AcceptabLE cDs)

Traumatic Brain InjuryVenous Thromboembolism
University of Minnesota15,000 enrolled1 locationNCT05628207
Recruiting
Phase 3

REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

Symptomatic Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled14 locationsNCT07213778
Recruiting
Phase 4

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Venous ThromboembolismVaricose Veins
Imperial College London6,660 enrolled1 locationNCT05735639
Recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis
Cook Research Incorporated82 enrolled7 locationsNCT05881798
Recruiting
Early Phase 1

Apixaban in Thrombocytopenia

ThrombocytopeniaDeep Vein ThrombosisPulmonary Embolism and Thrombosis+1 more
Rushad Patell30 enrolled1 locationNCT06886516
Recruiting
Phase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals2,000 enrolled41 locationsNCT07015905
Recruiting
Not Applicable

GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis

SurgeryVenous Thromboembolism
Imperial College London8,608 enrolled3 locationsNCT06166537
Recruiting

Aspiration Thrombectomy Using the Symphony or Prodigy System

Venous ThromboembolismArterial ThromboembolismPulmonary Embolism
Imperative Care, Inc.750 enrolled1 locationNCT07350499
Recruiting
Not Applicable

Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage

Venous ThromboembolismPulmonary EmbolismDeep Vein Thrombosis+1 more
Pirogov Russian National Research Medical University200 enrolled1 locationNCT06753786
Recruiting
Not Applicable

CLEANer Aspiration for Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+1 more
Argon Medical Devices125 enrolled14 locationsNCT06189313
Recruiting
Phase 2

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

Venous Thromboembolism
University of Miami5,478 enrolled1 locationNCT04295486
Recruiting

Caprini Score in Venous Surgery: a Prospective Cohort Study

Venous ThromboembolismVaricose Veins
Pirogov Russian National Research Medical University3,000 enrolled1 locationNCT03041805
Recruiting
Not Applicable

Early Exercise-Based Rehabilitation in Patients Hospitalized for Acute Pulmonary Embolism

Quality of Life (QOL)Exercise TherapyAnxiety Depression+7 more
Insel Gruppe AG, University Hospital Bern160 enrolled5 locationsNCT07143539
Recruiting
Not Applicable

Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

Venous Thromboembolism
Brigham and Women's Hospital400 enrolled1 locationNCT03728166
Recruiting

Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery

Lung Cancer (Diagnosis)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
The First Hospital of Jilin University900 enrolled1 locationNCT07439991
Recruiting

Impact of COVID-19 Vaccines on Cerebrovascular Health

DementiaBrain DiseasesStroke, Ischemic+7 more
Chinese University of Hong Kong500 enrolled1 locationNCT04992195
Recruiting
Phase 3

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Venous Thromboembolism (VTE)Postpartum
Marc Blondon9,200 enrolled1 locationNCT07140211
Recruiting
Not Applicable

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Deep Venous ThrombosisVenous Thromboembolism
Memorial Sloan Kettering Cancer Center259 enrolled8 locationsNCT07399977